Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 2, 2016, Pages 301-308.e2

  Kanwal, Fasiha ^a,b   Kramer, Jennifer R ^a,b   Duan, Zhigang ^a,b   Yu, Xiaoying ^b   White, Donna ^a,b   El Serag, Hashem B ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Epidemiology; Incidence; Metabolic Syndrome; Nonalcoholic Fatty Liver Disease; Prevalence

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; AGE; AGE DISTRIBUTION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PREVALENCE; TREND STUDY; UNITED STATES; VALIDATION STUDY; VETERAN; VULNERABLE POPULATION; CROSS-SECTIONAL STUDY; LIVER FUNCTION TEST; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREVALENCE; UNITED STATES; VETERANS; YOUNG ADULT;

EID: 84958919495     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.08.010     Document Type: Article

References (21)

1. Adams L.A., Lindor K.D. Nonalcoholic fatty liver disease. Ann Epidemiol 2007, 17:863-869.
2. Wattacheril J., Chalasani N. Nonalcoholic fatty liver disease (NAFLD): is it really a serious condition?. Hepatology 2012, 56:1580-1584.
3. Starley B.Q., Calcagno C.J., Harrison S.A. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010, 51:1820-1832.
4. Vernon G., Baranova A., Younossi Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011, 34:274-285.
5. Williams C.D., Stengel J., Asike M.I., et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011, 140:124-131.
6. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
7. Ruhl C.E., Everhart J.E. Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment Pharmacol Ther 2015, 41:65-76.
8. HSR&D. VA informatics and computing infrastructure. Available at: Accessed January 2015. http://www.hsrd.research.va.gov/for_researchers/vinci/.
9. Lapham G.T., Achtmeyer C.E., Williams E.C., et al. Increased documented brief alcohol interventions with a performance measure and electronic decision support. Med Care 2012, 50:179-187.
10. Using AUDIT-C alcohol screening data in VA research: interpretation, strengths, limitations, & sources. Available at: Accessed January 2015. http://www.hsrd.research.va.gov/for_researchers/cyber_seminars/archives/vci-031511.pdf.
11. Husain N., Blais P., Kramer J., et al. Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data. Aliment Pharmacol Ther 2014, 40:949-954.
12. Geiss L.S., Wang J., Cheng Y.J., et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA 2014, 312:1218-1226.
13. Joinpoint Regression Program, version 4.1.1. August 2014. Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute.
14. Clegg L.X., Hankey B.F., Tiwari R., et al. Estimating average annual per cent change in trend analysis. Stat Med 2009, 28:3670-3682.
15. Kim H.J., Fay M.P., Feuer E.J., et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000, 19:335-351. (correction 2001;20:655).
16. Angulo P., Hui J.M., Marchesini G., et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007, 45:846-854.
17. Flegal K.M., Carroll M.D., Kit B.K., et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012, 307:491-497.
18. Blais P., Husain N., Kramer J.R., et al. Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol 2015, 110:10-14.
19. Ruhl C.E., Everhart J.E. Upper limits of normal for alanine aminotransferase activity in the United States population. Hepatology 2012, 55:447-454.
20. Das S.R., Kinsinger L.S., Yancy W.S., et al. Obesity prevalence among veterans at Veterans Affairs medical facilities. Am J Prev Med 2005, 28:291-294.
21. Miller D.R., Safford M.M., Pogach L.M. Who has diabetes? best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 2004, 27(Suppl 2):B10-B21.